New and evolving concepts in the neurotoxicology of lead

Neuroscience

• Adverse Effect 33%
• Alzheimer's Disease 66%
• Amyloid Precursor Protein 33%
• Astrocyte 66%
• Beta Amyloid 33%
• Cell Growth 33%
• Cell Specificity 33%
• Chaperone 100%
• Cognitive Disorders 66%
• Cytokine 33%
• Dopamine 33%
• Glucocorticoid 66%
• Glucose Regulated Protein 33%
• Glucose Regulated Protein 78 33%
• Glutamic Acid 33%
• Hippocampus 66%
• In Vitro 33%
• Interleukin 6 66%
• Learning Disabilities 33%
• Long-Term Potentiation 33%
• Nervous System 66%
• Neurodegeneration 33%
• Neurogenesis 66%
• Neurotoxicology 100%
• NMDA Receptor 33%
• Synaptic Plasticity 66%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 33%
• Alzheimer's Disease 66%
• Amyloid Precursor Protein 33%
• Amyloid Protein 33%
• Chaperone 100%
• Cognitive Defect 66%
• Cytokine 33%
• Diseases 66%
• Dopamine 33%
• Glucocorticoid 66%
• Glucose Regulated Protein 33%
• Glucose Regulated Protein 78 33%
• Glutamic Acid 33%
• Interleukin 6 66%
• Lead Poisoning 33%
• Learning Disorder 33%
• N Methyl Dextro Aspartic Acid Receptor 33%
• Nerve Degeneration 33%
• Neurotoxicology 100%
• Toxicology 33%

Keyphrases

• Evolving Concepts 100%
• Protein Amyloid 25%